
Wayra UK to triple number of digital start-ups it supports
Wayra UK, part of Telefónica Open Future_, is to support more UK digital and tech start-ups in 2017 than ever before, thanks to a substantial increase in the number…

Wayra UK, part of Telefónica Open Future_, is to support more UK digital and tech start-ups in 2017 than ever before, thanks to a substantial increase in the number…

Some major banks are in advanced stages of planning to shift some operations from London to Paris.

The President-elect is also seen as potential driver of US growth

Port Talbot plant would remain open under rescue plan that could still be sunk if workers reject pensions overhaul

Sports Direct has posted a 25pc tumble in profits as the Mike Ashley-owned giant wrestles to restore a battered reputation and transform itself into the “Selfridges…

Regardless of the type of business you run you are no doubt worried about cash flow. This is understandable given the fact money is tight for…

Many who wish there were more hours in the day are set to rejoice as scientists work out how long it will be before we have…

An hour IT outage can cripple retail businesses, costing even small companies up to £100,000.

According to new research, employees are wasting valuable work hours looking for support in their roles, as they are unable to identify internal expertise from within…

As part of TCS’ ongoing work with MyKindaFuture (MKF), it was looking for exciting and dynamic companies to help tackle the current UK STEM skills shortage,…

Two fifths of workers would be more inclined to take a job if staff can work from home and one in five would be more willing…

Sadiq Khan has made no secret of his aims to tackle the capital's air pollution problem.

Treasury committee chair asks bank if £400m fund is underestimation of cost of meeting claims by GRG customers.

Sales of the Apple Watch have fallen by 71 per cent, with the company claiming a shrinking share of the market for wearable technology.

Drugs giant Pfizer has been fined a record £84.2m by the UK's competition watchdog for overcharging the NHS for an anti-epilepsy drug.